CR | PharmaTutor

14 June 2010

BITS Notice: Admission in M.Pharm, M.S and Various PG Diploma Programmes | Mersa

Applications are invited from eligible candidates for admission to the following postgraduate programmes of the Institute for the session 2010-11:

12 June 2010

Drug safety Associates requires at Icon Clinical research

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

27 May 2010

Job as Senior QA Auditor in Icon Clinical Research | Singapore, Bangalore

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialize in the strategic development, management and analysis of programs that support Clinical Development – from compound selection to Phase I - IV clinical studies

14 May 2010

Sr. Manager-Phamacovigilance required at Biocon

Biocon is a research-driven, global healthcare company with a strong matrix of capabilities along the biopharmaceutical value chain. Focusing on unmet medical needs in cancer, diabetes and inflammatory diseases, it offers novel therapies on a platform of affordable innovation.

12 May 2010

Lead Clinical Data Manager required at Novartis Healthcare

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

10 May 2010

ICON Plc (Chennai) requires Drug Safety Associates

ICON is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. We specialise in the strategic development, management and analysis of programs that support Clinical Development - from compound selection to Phase I-IV clinical studies

Post:Drug Safety Associate

7 April 2010

LCT gets approval to advance to phase-II human trial with Diabecell

Living Cell Technologies Limited, a global company pioneering the development of a cell implant to treat diabetes, has received approval to advance to the next phase of its New Zealand phase-II human clinical trial with its groundbreaking Diabecell. The approval follows a positive assessment from the New Zealand Data Safety and Monitoring Board of the first four patients to receive its Diabecell implants.

24 March 2010

Deaths during clinical trials on rise as India turning as hot destination

Even as the dust is yet to settle down over the HPV vaccine trial and death of three tribal girls in Andhra Pradesh, records showed that the total number of deaths among the clinical trial subjects, though not officially termed as part of the trials, are on the increase in India.

17 March 2010

Several drugs to come under regulatory scanner as national pharmacovigilance programme to begin in April

Two H1N1 drugs - oseltamivir and zanamavir, the controversial sub-fertility drug letrozole, popular non-steroidal anti-inflammatory drug nimesulide, decongestant drug phenylpropanolamine (PPA), antibiotic drug gatifloxacine, chronic constipation drug tegaserod, type-2 diabetes drug pioglitazone and rosiglitazone have been selected for the first phase of national pharmacovigilance programme which will begin in select 40 medical colleges across the country from April this year.

3 March 2010

Senior Clin Ops Manager - Philippines at Resourse Scientific

Resourse Scientific

Senior Clin Ops Manager - Philippines